Online
Cipla
BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | Pharmaceuticals
Buy Cipla, target of Rs 370: Hem Securities
Hem Securities has come out with a research report on Cipla. The research firm has initiated a buy signal on the stock with a target price of Rs 370 i...
10-11-2009
06-11-2009: Buy Cipla, says Sudarshan Sukhani
04-11-2009: Hold Cipla, target Rs 335: KR Choksey
28-10-2009: Maintains topline guidance of 10-12% for FY10: Cipla
28-10-2009: Cipla Q2 net up 83%, targets exports of Rs 3K cr in FY10
Cipla
Buy Cipla, target of Rs 370: Hem Securities
Hem Securities has come out with a research report on Cipla. The research firm has initiated a buy signal on the stock with a target price of Rs 370 i...
10-11-2009
04-11-2009: Hold Cipla, target Rs 335: KR Choksey
07-10-2009: Hold Cipla: Indiabulls Securities
28-08-2009: Reduce Cipla, target of Rs 238: Angel
30-07-2009: Buy Cipla, target of Rs 286: KRChoksey
Daiichi says to help Ranbaxy overcome US FDA woes
Japan's Daiichi Sankyo, which controls Ranbaxy Laboratories, said it will help the Indian drug maker overcome its problems with the US Food and Drug A...
10-11-2009
09-11-2009: AstraZeneca takes Lupin to NJ court over Nexium
07-11-2009: Dr Reddy's files for marketing Lipitor generic
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
06-11-2009: Sun Pharma gets US nod for generic Acular
Peers
Sun Pharma underperformer, target Rs 1355: Karvy
Karvy Stock Broking has recommended an underperformer rating on Sun Pharmaceuticals, with price target of Rs 1355, in its report dated November 6, 200...
06-11-2009
10-11-2009: Nifty slips in red; Hero Honda, HUL, DLF down
10-11-2009: Emergency pills to maintain OTC drug status
07-11-2009: Cholesterol drug sales set to double
03-11-2009: Nifty ends below 4550; Suzlon,Hindalco,DLF fall
03-11-2009: Nifty consolidates; Bajaj, Bharti upTuesday, November 3, 2009,10:15 [IST]
03-11-2009: EU seizes another generic package
02-11-2009: India is growth tonic for mid-tier global pharma
02-11-2009: Pharma slows down, grows at 9.6%
01-11-2009: Indian companies on African safari in search of new markets
29-10-2009: Sun Pharma earnings decline less-than-expected, Cipla earnings jump 82 per cent on forex gains
29-10-2009: Tata Tea net leaps 32%; GAIL profit plummets 30%
29-10-2009: Sell-off, weak global cues drag mkts downWednesday, October 28, 2009,10:18 [IST]
29-10-2009: Different product mix helped cut material costs
29-10-2009: Cipla, Sun Pharma post smaller sales growth
28-10-2009: Cipla sales growth slows, but net profit close to expectations
28-10-2009: Mkts bounce back on buying in RIL, L&T, WiproWednesday, October 28, 2009,10:18 [IST]
28-10-2009: Nifty climbs above 4800; realty, banks down
28-10-2009: Stocks to watch: Vishal Retail, Binani Cement, SCI, Premier Explosives, Sasken Communications, HCL, Ispat
26-10-2009: Lead Runners: Stocks that hit all-time highs
24-10-2009: Cipla Ltd Long Term Buy Call: Abhishek Jain, StocksIdea.com
10-11-2009: Emergency pills to maintain OTC drug status
08-11-2009: Recovery tempered by challenges
06-11-2009: Sensex: Hat-trick of gains
06-11-2009: Sensex ends above 16k mark; SBI, ITC gainThursday, November 5, 2009,10:23 [IST]
03-11-2009: EU seizes another generic package
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
07-11-2009: Nifty ends higher; Suzlon, Jaiprakash gainFriday, November 6, 2009,10:17 [IST]
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
31-10-2009: Sensex loses 5.44 percent in week
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
09-11-2009: Generics Gateway
07-11-2009: HHS Orders Intravenous Antiviral Flu Medication To Help Patients Hospitalized With 2009 H1N1
07-11-2009: Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States
07-11-2009: Aurobindo drug gets US nod
08-11-2009: Recovery tempered by challenges
06-11-2009: NSE's stock options trade fails to mirror revival
28-10-2009: Lupin bets on Japanese elders
27-10-2009: Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
